Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $988,557 | 22 | 98.9% |
| Food and Beverage | $10,487 | 457 | 1.0% |
| Travel and Lodging | $800.00 | 1 | 0.1% |
| Education | $76.85 | 3 | 0.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44.61 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ceribell, Inc. | $990,603 | 39 | $0 (2024) |
| ABBVIE INC. | $2,029 | 121 | $0 (2024) |
| UCB, Inc. | $928.41 | 44 | $0 (2024) |
| SK Life Science, Inc. | $648.69 | 26 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $635.83 | 24 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $521.17 | 22 | $0 (2021) |
| Biogen, Inc. | $438.69 | 21 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $363.88 | 20 | $0 (2024) |
| Allergan, Inc. | $310.34 | 20 | $0 (2021) |
| LivaNova USA, Inc. | $253.61 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $371,779 | 133 | Ceribell, Inc. ($369,583) |
| 2023 | $350,592 | 82 | Ceribell, Inc. ($349,038) |
| 2022 | $203,341 | 54 | Ceribell, Inc. ($202,179) |
| 2021 | $62,181 | 100 | Ceribell, Inc. ($60,345) |
| 2020 | $3,066 | 68 | Ceribell, Inc. ($1,793) |
| 2019 | $8,424 | 36 | Ceribell, Inc. ($7,600) |
| 2018 | $583.06 | 12 | LivaNova USA, Inc. ($210.43) |
All Payment Transactions
485 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Consulting Fee | Cash or cash equivalent | $41,652.22 | General |
| Category: Neurology | ||||||
| 12/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Central Nervous System | ||||||
| 12/14/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Rare Disease | ||||||
| 12/12/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $124.19 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Neurology | ||||||
| 12/08/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $160.71 | General |
| Category: Neurology | ||||||
| 12/06/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/06/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/01/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Consulting Fee | Cash or cash equivalent | $30,750.00 | General |
| Category: Neurology | ||||||
| 12/01/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| Category: Neurology | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $26.09 | General |
| Category: Neurology | ||||||
| 11/20/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Neurology | ||||||
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/13/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $177.20 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $33.55 | General |
| Category: Neurology | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 761 | 1,010 | $533,366 | $143,753 |
| 2022 | 18 | 731 | 954 | $487,654 | $128,401 |
| 2021 | 17 | 752 | 1,063 | $386,020 | $155,535 |
| 2020 | 19 | 826 | 1,152 | $415,453 | $160,924 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 77 | 163 | $90,139 | $27,867 | 30.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 62 | 118 | $87,674 | $20,124 | 23.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 31 | 32 | $41,568 | $12,855 | 30.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 37 | 37 | $40,885 | $12,635 | 30.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 75 | 122 | $32,452 | $11,996 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 99 | $34,155 | $10,062 | 29.5% |
| 95717 | Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report | Facility | 2023 | 77 | 83 | $22,244 | $6,942 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 43 | $20,855 | $6,635 | 31.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 47 | $24,158 | $6,479 | 26.8% |
| 95724 | Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional | Facility | 2023 | 18 | 18 | $15,390 | $4,749 | 30.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $15,366 | $4,396 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 63 | $15,435 | $3,852 | 25.0% |
| 95726 | Measurement of brain wave activity with video (veeg), more than 84 hours with review and report by health care professional | Facility | 2023 | 11 | 11 | $11,935 | $3,684 | 30.9% |
| 95722 | Measurement of brain wave activity with video (veeg), 37-60 hours with review and report by health care professional | Facility | 2023 | 12 | 12 | $8,076 | $2,497 | 30.9% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2023 | 32 | 32 | $17,680 | $2,297 | 13.0% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 16 | 17 | $6,103 | $1,778 | 29.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 27 | 28 | $30,940 | $1,312 | 4.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $5,811 | $1,154 | 19.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 16 | $2,960 | $1,061 | 35.8% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2023 | 19 | 19 | $5,938 | $853.92 | 14.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 11 | 11 | $3,603 | $521.84 | 14.5% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 77 | 161 | $89,033 | $28,676 | 32.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 47 | 47 | $51,935 | $16,944 | 32.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 47 | 76 | $56,468 | $14,123 | 25.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 28 | 31 | $38,326 | $12,585 | 32.8% |
About Dr. Parshaw Dorriz, MD
Dr. Parshaw Dorriz, MD is a Neurology healthcare provider based in Mission Viejo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1972940625.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Parshaw Dorriz, MD has received a total of $999,965 in payments from pharmaceutical and medical device companies, with $371,779 received in 2024. These payments were reported across 485 transactions from 54 companies. The most common payment nature is "Consulting Fee" ($988,557).
As a Medicare-enrolled provider, Dorriz has provided services to 3,070 Medicare beneficiaries, totaling 4,179 services with total Medicare billing of $588,613. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Mission Viejo, CA
- Active Since 06/03/2013
- Last Updated 10/21/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1972940625
Products in Payments
- Ceribell Rapid Response EEG (Device) $409,383
- POCKET EEG DEVICE (Device) $369,583
- Rapid Response EEG (Device) $202,179
- UBRELVY (Drug) $965.49
- Briviact (Drug) $773.53
- BOTOX (Biological) $673.49
- NUPLAZID (Drug) $491.68
- QULIPTA (Drug) $470.49
- TROKENDI XR (Drug) $437.35
- NURTEC ODT (Drug) $252.65
- TYSABRI (Biological) $239.23
- Austedo XR (Drug) $236.74
- VNS Therapy (Device) $210.43
- GOCOVRI (Drug) $195.51
- ULTOMIRIS (Biological) $147.49
- DAYBUE (Drug) $144.15
- KYNMOBI (Drug) $135.96
- DUOPA (Drug) $135.69
- Epidiolex (Drug) $134.00
- EMGALITY (Drug) $127.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Mission Viejo
Eleonora Spokoyny, Md, MD
Neurology — Payments: $16,822
Hamid Salehi, Md, MD
Neurology — Payments: $8,363
Theodore Teacher, Md, MD
Neurology — Payments: $7,057
Marco Lopez Vizcarra, M.d, M.D
Neurology — Payments: $991.95
Fred Nour, Md, MD
Neurology — Payments: $642.32
Dr. Stephen Jenkins, M.d, M.D
Neurology — Payments: $387.26